Brief: Acasti Announces Year-End 2024 Financial Results, Provides Business Update
June 21 (Reuters) - Acasti Pharma Inc ACST.O :
* ACASTI ANNOUNCES YEAR-END 2024 FINANCIAL RESULTS, PROVIDES
BUSINESS UPDATE
* ACASTI PHARMA INC: PROJECTED CASH RUNWAY INTO SECOND
CALENDAR
QUARTER 2026
* ACASTI PHARMA: PATIENT ENROLLMENT IN PIVOTAL STRIVE-ON
PHASE 3
SAFETY TRIAL FOR GTX-104 ON-TRACK FOR POTENTIAL NDA SUBMISSION
IN 1H CALENDAR 2025
Source text for Eikon: ID:nGNX2dnDy4
Further company coverage: ACST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grace Therapeutics
See all newsBrief: Grace Therapeutics - Selling Stockholders May Resell Up To 4,761,904 Shares Of Common Stock - SEC Filing
Grace Therapeutics Q1 net loss widens on impairment charges
Grace Therapeutics falls after FDA declines to approve stroke drug
NASDAQ RESUMED AT 01:57 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:52 PM